COMMUNIQUÉS West-GlobeNewswire

New Phase 2 study with filgotinib in non-infectious uveitis

05/07/2017 - 07:30

Mechelen, Belgium; 5 July 2017; 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces a new Phase 2 study investigating filgotinib in non-infectious uveitis, being led by filgotinib collaboration partner [...]

ESPERITE (ESP): L1 Capital subscribes to the fourth packed tranche of investment today

05/07/2017 - 07:17

Zutphen, The Netherlands, 5 July 2017 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a fourth Packed Tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the " [...]

NEOVACS ANNOUNCES LICENSE AGREEMENT FOR IFNalpha KINOID FOR TREATMENT OF LUPUS IN TURKEY

05/07/2017 - 07:00

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES LICENSE AGREEMENT FOR IFNalpha KINOID FOR TREATMENT OF LUPUS IN TURKEY Agreement grants Centurion Pharma exclusive license to market IFNalpha Kinoid in [...]

NEOVACS ANNONCE LA SIGNATURE D'UN ACCORD DE LICENCE POUR L'IFNalpha KINOIDE DANS LE TRAITEMENT DU LUPUS EN TURQUIE

05/07/2017 - 07:00

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NEOVACS ANNONCE LA SIGNATURE D'UN ACCORD DE LICENCE POUR L'IFNalpha KINOIDE DANS LE TRAITEMENT DU LUPUS EN TURQUIE Dans le cadre de cet accord, [...]

IBA SA : IBA Déclaration Intermédiaire

05/07/2017 - 07:00

IBA Déclaration Intermédiaire Une conférence téléphonique au sujet de cette déclaration intermédiaire se tiendra ce jour à 15h CEST, 14h BST, 9h EST. Louvain-La-Neuve, Belgique, le 5 juillet 2017 - IBA (Ion Beam [...]

IBA SA : IBA Trading Update

05/07/2017 - 07:00

IBA Trading Update A conference call to discuss the trading update will be held today at 3pm CEST, 2pm BST, 9am EDT, details below. Louvain-La-Neuve, Belgium, July 5, 2017 - IBA (Ion Beam Applications S.A., EURONEXT), [...]

Saniona AB: Saniona buys out payment obligation to NeuroSearch

04/07/2017 - 18:00

PRESS RELEASE 4 July 2017 Saniona, a leading biotech company in the field of ion channels, today announce that it has acquired NeuroSearch's remaining interest in the preclinical and clinical assets, which Saniona [...]

CellaVision AB presents the second quarter 2017 on July 18 at 11:00 CET

04/07/2017 - 08:20

Pdf This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]

Sanofi : Disclosure of trading in own shares

03/07/2017 - 18:00

Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Sanofi : Déclaration des transactions sur actions propres

03/07/2017 - 18:00

Reporting FR This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Ossur Hf : Transactions in relation to share buyback program

03/07/2017 - 18:00

Announcement from Össur hf. No. 47/2017 Reykjavík, 3 July 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]

NICOX : Déclaration des droits de vote au 30 juin 2017

03/07/2017 - 17:45

Nicox SA Société anonyme au capital de 25 669 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 juillet 2017, PUBLICATION MENSUELLE DU NOMBRE D' [...]

NICOX : Number of voting rights as of June 30. 2017

03/07/2017 - 17:45

Nicox SA Société anonyme with a registered capital of € 25,669,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On July 3, 2017, MONTHLY PUBLICATION OF THE [...]

IBA SA : IBA - NOTIFICATION DE TRANSPARENCE

03/07/2017 - 17:45

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 3 juillet 2017, 17h40 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]

IBA SA : IBA - TRANSPARENCY NOTIFICATION

03/07/2017 - 17:45

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, July 03, 2017, 5.40 p.m. - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

Une nouvelle étude avec la pompe cardiaque Impella 2.5® d'Abiomed démontre une survie potentielle avec l'insertion pré ICP dans les crises cardiaques avec l'artère coronaire principale gauche

03/07/2017 - 14:36

DANVERS, Massachusetts, July 3, 2017 (GLOBE NEWSWIRE) - Abiomed, Inc . (NASDAQ : ABMD), fournisseur majeur de technologies innovantes d'assistance et de récupération cardiaque, a annoncé aujourd'hui la publication [...]

Shire plc : Director/PDMR Shareholding

03/07/2017 - 14:30

Director/PDMR Shareholding July 3, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Bavarian Nordic Issues Warrants to Newly Appointed Member of the Executive Management

03/07/2017 - 13:48

COPENHAGEN, Denmark, July 3, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that the Board of Directors in Bavarian Nordic A/S has decided to issue warrants to Tommi Kainu, newly appointed Chief [...]

Status regarding Novo Nordisk's holding of its own shares (30 June 2017)

03/07/2017 - 13:29

Bagsværd, Denmark, 3 July 2017 - In continuation of the company's announcements dated 2 February 2017 and 3 May 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock [...]